Related Experiment Videos

Kawasaki disease in Greek children: a retrospective study

A Alexopoulos1, A Vekiou, L Lycopoulou

  • 1alexis.alexopoulos@yahoo.com

Insights

Kawasaki disease (KD) in Greek children shows similar epidemiology to other populations. Early diagnosis and treatment are crucial, as significant cardiac complications, including coronary artery aneurysms, can still occur.

Area of Science:

  • Pediatric Rheumatology
  • Infectious Diseases
  • Cardiology

Background:

  • Studies on Kawasaki disease (KD) in Greek children are limited.
  • This study addresses the lack of epidemiological data on KD in Greece.

Purpose of the Study:

  • To evaluate the epidemiology, clinical features, laboratory findings, and outcomes of complete KD in Greek children.
  • To assess the incidence of cardiac complications in treated pediatric KD patients.

Main Methods:

  • Retrospective analysis of 49 children diagnosed with complete KD between 2004 and 2011.
  • Data collected via standardized forms, including clinical presentation, treatment response, and echocardiographic findings.

Main Results:

  • A seasonal peak in spring and summer was observed.
  • 17% of patients developed coronary artery abnormalities, with 2 cases resulting in aneurysms requiring surgery.
  • Most patients responded well to initial intravenous immunoglobulin (IVIG) treatment.

Conclusions:

  • Epidemiological features of KD in Greece align with international findings.
  • Despite early diagnosis and treatment, significant cardiac complications remain a concern in pediatric KD.
  • Prompt management is essential to mitigate long-term cardiovascular sequelae.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...